Cargando…
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice
SIMPLE SUMMARY: Glioblastomas (GBMs) are difficult-to-treat, deadly brain tumors and may infiltrate the whole brain. Cancer-killing (oncolytic) viruses have been used to treat GBMs. However, oncolytic virotherapy needs surgery, as the viruses have to be injected directly into the tumor. Human hepati...
Autores principales: | El-Ayoubi, Ali, Klawitter, Moritz, Rüttinger, Jakob, Wellhäusser, Giulia, Holm, Per Sonne, Danielyan, Lusine, Naumann, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605419/ https://www.ncbi.nlm.nih.gov/pubmed/37894279 http://dx.doi.org/10.3390/cancers15204912 |
Ejemplares similares
-
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model
por: Klawitter, Moritz, et al.
Publicado: (2022) -
Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells
por: Czolk, Rebecca, et al.
Publicado: (2019) -
Concepts in Oncolytic Adenovirus Therapy
por: Mantwill, Klaus, et al.
Publicado: (2021) -
YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells
por: Mantwill, Klaus, et al.
Publicado: (2013) -
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
por: Koch, Jana, et al.
Publicado: (2022)